glp-1 shortage update news 2025 november = Over GLP-1 Pipeline Update: August 2025 GLP-1 No Longer on FDA's

Evaluating anhedonia as a risk factor in suicidality: a meta-analysis

Once the seal is compromised or a vial is punctured, standard laboratory sterile protocols should be followed, and the material should be evaluated within a condensed timeline to prevent contamination

Multi-target research focuses on GLP-1, GIP, and GCG receptors, with multi-target drugs based on GLP-1 receptors gradually becoming a hot area in blood sugar regulation and weight loss

GLP-1 medications and related incretin therapies can make food feel different: appetite drops, fullness arrives earlier, rich foods may sit heavily, and old meal-prep habits may stop working